论文部分内容阅读
文章报道了对30例健康者和114例心血管病患者血清SOD、MDA含量的检测结果.结果表明:(1)心血管病患者与健康对照组比较:SOD降低有非常显著性差异(P<0.01～≤0.0001);MDA升高有显著或极显著差异(P<0.05～0.01).(2)不同时期高血压病患者血清SOD含量与健康组比较:高血压病Ⅱ期患者无显著性差异(P>0.05),Ⅲ期则降低有极显著性差异(P>0.05).MDA与健康组比较,Ⅱ、Ⅲ期患者均无显著性差异(P>0.05).(3)不同级别心功能(按NYHA标准)患者与健康组比较,SOD降低均有显
The article reported the results of the detection of serum SOD and MDA in 30 healthy subjects and 114 cardiovascular patients.The results showed that: (1) There was a significant difference in the decrease of SOD between patients with cardiovascular diseases and healthy controls (P < 0.01 ~ ≤0.0001). There was a significant or very significant difference in the level of MDA (P <0.05 ~ 0.01). (2) Compared with healthy group, there was no significant difference in serum SOD between patients with hypertension and stage Ⅱ (P> 0.05), but there was no significant difference between the two groups (P> 0.05). (3) Different levels of cardiac function (According to the NYHA standard) patients and healthy group, SOD decreased significantly